In this study, we have uncovered several mutations in KDM6A, specifically H101D & P110S, N1156T and D1216N, identified in ESCC patients, increase the capability of interaction with SND1, leading to genotoxin resistance. This evidence concerns the gene KDM6A and esophageal squamous cell carcinoma.